Swiss Biotech Startup Vale Biolabs Secures €164k Grant to Advance AI-Driven Brain Disease Research Platform
Swiss biotech startup Vale Biolabs secured a €164k grant from the Swiss accelerator Venture Kick to accelerate its AI‑driven human brain organoid platform, aiming to improve pre‑clinical testing for neurological diseases and reduce reliance on animal models.